tiprankstipranks
Advertisement
Advertisement

MX:VRTX Stock Latest News

Arcturus Therapeutics price target raised to $41 from $20 at Roth Capital
The FlyArcturus Therapeutics price target raised to $41 from $20 at Roth Capital
2d ago
ARCT
VRTX
Vertex Pharmaceuticals resumed with an Overweight at Morgan Stanley
PremiumThe Fly
Vertex Pharmaceuticals resumed with an Overweight at Morgan Stanley
2d ago
VRTX
Vertex Pharmaceuticals completes acquisition of Crinetics Pharmaceuticals
PremiumThe Fly
Vertex Pharmaceuticals completes acquisition of Crinetics Pharmaceuticals
3d ago
CRNX
VRTX
Vertex Pharmaceuticals added to US Conviction List at Goldman Sachs
PremiumThe Fly
Vertex Pharmaceuticals added to US Conviction List at Goldman Sachs
3d ago
VRTX
Argenx price target raised to $1,250 from $1,230 at Morgan Stanley
PremiumThe Fly
Argenx price target raised to $1,250 from $1,230 at Morgan Stanley
4d ago
ARGX
VRTX
Private Markets: $1B for Base Power, $545M for Whatnot
PremiumThe FlyPrivate Markets: $1B for Base Power, $545M for Whatnot
15d ago
U
GD
Private Markets: Databricks secures $5B as Kalshi targets $40B valuation
Premium
The Fly
Private Markets: Databricks secures $5B as Kalshi targets $40B valuation
18d ago
AI
IBM
Vertex: Competitive Threat Eases, Pipeline Strength Supports Unchanged $600 Price Target and Buy Rating
Premium
Ratings
Vertex: Competitive Threat Eases, Pipeline Strength Supports Unchanged $600 Price Target and Buy Rating
24d ago
VRTX
Vertex Pharmaceuticals added to ‘US 1 List’ at BofA
PremiumThe Fly
Vertex Pharmaceuticals added to ‘US 1 List’ at BofA
24d ago
VRTX
Sionna Therapeutics downgraded to Neutral at Guggenheim after trial miss
PremiumThe Fly
Sionna Therapeutics downgraded to Neutral at Guggenheim after trial miss
24d ago
SION
VRTX
Vertex Pharmaceuticals price target raised to $672 from $605 at BofA
PremiumThe Fly
Vertex Pharmaceuticals price target raised to $672 from $605 at BofA
25d ago
SION
VRTX
Early notable gainers among liquid option names on August 10th
PremiumThe Fly
Early notable gainers among liquid option names on August 10th
25d ago
APA
AKAM
Vertex Pharmaceuticals price target raised to $565 from $560 at Truist
PremiumThe FlyVertex Pharmaceuticals price target raised to $565 from $560 at Truist
30d ago
VRTX
Vertex Pharmaceuticals price target raised to $617 from $615 at Barclays
Premium
The Fly
Vertex Pharmaceuticals price target raised to $617 from $615 at Barclays
30d ago
VRTX
Vertex Pharmaceuticals Ups 2026 Outlook Amid Heavy Investment
Premium
Company Announcements
Vertex Pharmaceuticals Ups 2026 Outlook Amid Heavy Investment
1M ago
VRTX
Vertex: Strong Q2 Beat and Raised Revenue Outlook Underpin Buy Rating and Broadening Growth Beyond CF
PremiumRatings
Vertex: Strong Q2 Beat and Raised Revenue Outlook Underpin Buy Rating and Broadening Growth Beyond CF
1M ago
VRTX
Vertex: Buy Rating Reaffirmed with Unchanged $585 Price Target on Strong CF Performance and Late-Stage Pipeline Upside
PremiumRatings
Vertex: Buy Rating Reaffirmed with Unchanged $585 Price Target on Strong CF Performance and Late-Stage Pipeline Upside
1M ago
VRTX
Vertex: Solid CF Fundamentals and Early Pipeline Credit Drive Price Target Raise to $442, Hold Rating Maintained
PremiumRatings
Vertex: Solid CF Fundamentals and Early Pipeline Credit Drive Price Target Raise to $442, Hold Rating Maintained
1M ago
VRTX
Vertex Pharmaceuticals: Solid Q2 Beat and Raised 2026 Guidance, But Early-Stage Diversification and CRNX Integration Keep Rating at Hold
PremiumRatings
Vertex Pharmaceuticals: Solid Q2 Beat and Raised 2026 Guidance, But Early-Stage Diversification and CRNX Integration Keep Rating at Hold
1M ago
VRTX
Vertex Upgraded to Buy as Strong Q2, Raised 2026 Guidance and Higher $605 Price Target Signal Durable, Diversified Growth
PremiumRatingsVertex Upgraded to Buy as Strong Q2, Raised 2026 Guidance and Higher $605 Price Target Signal Durable, Diversified Growth
1M ago
VRTX
Vertex Pharmaceuticals price target raised to $605 from $600 at BofA
Premium
The Fly
Vertex Pharmaceuticals price target raised to $605 from $600 at BofA
1M ago
VRTX
Vertex Pharmaceuticals price target raised to $595 from $590 at Cantor Fitzgerald
Premium
The Fly
Vertex Pharmaceuticals price target raised to $595 from $590 at Cantor Fitzgerald
1M ago
VRTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >